Study on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) in 2nd Line Treatment Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy Under Real-real Life Clinical Setting in France.

First posted Oct 30, 2020

Carnosine Supplementation and Cardiovascular Function

100 participants · First posted Feb 13, 2023

Helmsley 3.0: Abbreviated MRE

300 participants · First posted Aug 1, 2024

Canaline

C₄H₁₀N₂O₃

Carnosine

C₉H₁₄N₄O₃

Carpaine

Caroline Medical Group

Canada

BENTLEY INNOMED GMBH

France

Bentley Laboratories LLC

United States

Xilio Therapeutics Strengthens Leadership Team with New Chief Legal Officer Amid Advancement of Tumor-Activated Immunotherapy Pipeline

CAR-T Therapy Neurotoxicity May Not Always Be Inflammation-Related, Study Finds

AI-Powered Histology Biomarker Predicts Aggressiveness in Muscle-Invasive Bladder Cancer